Want to track DUL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DUL earnings report is expected in 64 days (29 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | 1.59 | - |
| | | - | - |
| | | 1.5 | - |
| | | 1.75 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
DUL Earnings Reports FAQ
What is the earnings per share (EPS) for DUL?
The current EPS is -3.56.
What is the company's earnings growth rate?
Alnylam Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-29, based on the DUL's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alnylam Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DUL at this time, as Alnylam Pharmaceuticals Inc has no recent EPS data to calculate it.
